Ethical Challenges in COVID-19 Biospecimen Research: Perspectives From Institutional Review Board Members and Bioethicists
Maria I. Lapid et al
Mayo Clin Proc. 2021;96(x):xx-xx. Tam metin için tıklayınız

Biospecimen research is a prominent investigative strategy that aims to
provide novel insights into coronavirus disease 2019 (COVID-19), inform clinical trials,
and develop effective, life-saving treatments. However, COVID-19 biospecimen research
raises accompanying ethical concerns and practical challenges for investigators and
participants. In this special article, we discuss the ethical issues that are associated with
autonomy, beneficence, and justice in COVID-19 biospecimen research and describe
strategies to manage the practical challenges, with an emphasis on protecting the rights
and welfare of human research participants during a pandemic response. Appropriate
institutional review board oversight and bioethics guidance for COVID-19 biospecimen
research must maintain their focus on protecting the rights and welfare of research
participants, despite the urgent need for more knowledge about the virus and the threat it
poses to communities and nations.

Comments: (0)